Health insurance coverage of genetic services in Illinois

Genetics in Medicine

Volumn 12, Issue 8, 2010, Pages 525-531

  Latchaw, Megan ^a,b   Ormond, Kelly ^a,c   Smith, Maureen ^a   Richardson, John ^d   Wicklund, Catherine ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c STANFORD UNIVERSITY   (United States)

^d National Society of Genetic Counselors   (United States)

Author keywords

coverage; genetic counseling; genetic services; health insurance; policy

Indexed keywords

ARTICLE; CYSTIC FIBROSIS; GENETIC SERVICE; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH PRACTITIONER; HEALTH SURVEY; HUMAN; UNITED STATES;

DATA COLLECTION; GENETIC SERVICES; HUMANS; ILLINOIS; INSURANCE CARRIERS; INSURANCE, HEALTH; INTERVIEWS AS TOPIC;

EID: 77955658893     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181e3916d     Document Type: Article

References (31)

1. Secretary's Advisory Committee on Genetics, Health, and Society. Coverage and reimbursement of genetic tests and services. US Department of Health and Human Services 2006. Available at: http://www4.od.nih.gov/oba/sacghs/reports/CR- report.pdf.
2. Harrison TL, Doyle DL, McGowan C, et al. Billing for medical genetics and genetic counseling services: a national survey. J Genet Couns 2010;19:38-43.
3. Williams MS. Genetics and managed care: policy statement of the American College of Medical Genetics. Genet Med 2001;3:430-435.
4. Gibons A. Study results: employer-based coverage of genetic counseling services. Benefits Q 2004;20:48-68.
5. Billings PR, Carlson RJ, Carlson J, et al. Ready for genomic medicine? Perspectives of health care decision makers. Arch Intern Med 2005;165:1917-1919.
6. Kuerer HM, Hwang ES, Anthony JP, et al. Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery. Ann Surg Oncol 2000;7:325-332.
7. Illinois Department of Public Health. Illinois state genetics plan. Springfield, IL: Office of Health Promotion 2007. Available at: www.idph.state.il.us/HealthWellness/Genetics-07StatePlan.pdf. Accessed June 1 2010.
8. Illinois Department of Insurance. Market share report 2006. Available at: http://www.idfpr.com/DOI/Reports/Report-Links.asp.
9. Social Security Act, 1965. Available at: http://www.ssa.gov/OP-Home/ ssact/ssact.htm.
10. Illinois Medical Practice Act of 1987. 225 ILCS 60. Available at: http://www.ilga.gov/.
11. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453-1456.
12. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatel-lite instability. J Natl Cancer Inst 2004;96:261-268. (Pubitemid 38256271)
13. Humana. Medical coverage policy: genetic testing/genetic counseling/pharmacogenetic testing. Available at: http://apps.humana.com/tad/ tad- new/returnContent.asp?mime=application/pdf&id=5298&issue=608. Accessed January 4, 2008.
14. Watson MS. Current status of newborn screening: decision-making about the conditions to include in screening programs. Ment Retard Dev Disabil Res Rev 2006;12:230-235.
15. Greendale K, Pyeritz RE. Empowering primary care health professionals in medical genetics: how soon? How fast? How far? Am J Med Genet 2001; 106:223-232.
16. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005;143:355-361.
17. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21:2397-2406.
18. Daly MB, Axilbund JE, Bryant E, et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 2006;4:156-176.
19. American College of Medical Genetics. Genetic susceptibility to breast and ovarian cancer: assessment, counseling and testing guidelines. New York: New York State Department of Health, American College of Medical Genetics Foundation, 1999. Available at: http://www.health.state.ny.us/nysdoh/cancer/ obcancer/contents.htm. Accessed June 1, 2010.
20. Myriad Genetic Laboratories, Inc. Myriad Genetics launches direct to consumer advertising for breast cancer test, 2002. Available at: http://www.myriad.com/news/release/333030.
21. Mouchawar J, Hensely-Alford S, Lauion S, et al. Impact of direct-to-con-sumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med 2005;7:191-197. (Pubitemid 40478156)
22. Centers for Disease Control and Prevention (CDC). Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing\Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR Morb Mortal Wkly Rep 2004;53:603-606.
23. Caulfield T, Bubela T, Murdoch CJ. (2007). Myriad and the mass media: the covering of a gene patent controversy. Genet Med 2007;9:850-855.
24. Committee on Genetics, American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Number 325, December 2005. Update on carrier screening for cystic fibrosis. Obstet Gynecol 2005 106 1465-1468.
25. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109: 217-227.
26. Berliner JL, Fay AM. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 2007;16:241-260.
27. OMIM (Online Mendelian Inheritance in Man). 175100: Adenomatous polyposis of the colon. Baltimore: Johns Hopkins University, Center for Medical Genetics 1996. Available at: http://www.ncbi.nlm.nih.gov/omim/175100. Accessed June 1 2010.
28. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997;336:823-827.
29. Hayflick SJ, Eiff MP, Carpenter L, Steinberger J. Primary care physicians' utilization and perceptions of genetics services. Genet Med 1998;1:13-21.
30. Cohn GM, Gould M, Miller RC, Habecker-Green J, Macri CJ, Gimovsky ML. The importance of genetic counseling before amniocentesis. J Perinatol 1996;16:352-357.
31. Boom JA, Nelson CS, Middleman AB, Frugé A, Kozinetz CA. Investigation of obstacles to accessing information regarding private medical insurance coverage and physician reimbursement for adolescent vaccination. J Adolesc Health 2009;44:298-301.